First and second biopsies and their diagnostic accuracy

A paper by Wong et al. published in December carries the title, “Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer.” … READ MORE …

Published data on Klotz’s active surveillance series at c. 20 years

In a report published on line on Monday, in the Journal of Clinical Oncology, Klotz et al. have now provided peer-reviewed data from their nearly 20-year-long series of patients managed on active surveillance. … READ MORE …

New draft Australian guidelines (on screening and expectant management)

A group of Australian experts has just released new draft guidance on prostate cancer screening and the role of expectant management (active surveillance and/or watchful waiting) in the management of prostate cancer. … READ MORE …

Consensus statement on pathologic factors and active surveillance

As previously mentioned earlier this week, a long statement that deals with the role of the pathologist in determining the suitability of patients for enrollment into active surveillance management protocols has been issued and endorsed by a number of organizations. … READ MORE …

Increasing consensus on eligibility criteria for active surveillance

A paper in the journal Virchows Archiv suggests increasing consensus on both inclusion criteria for management on active surveillance and progression criteria suggesting the need for active treatment. … READ MORE …

Active surveillance for men with Gleason 3 + 4 = 7 disease

The “New” Prostate Cancer InfoLink has taken the position for quite a while that active surveillance could well be a highly appropriate management strategy for some men  with a Gleason score of 3 + 4 = 7 at diagnosis (but far from all of them) — if they still met certain other criteria as good candidates for this form of management. … READ MORE …

When is active surveillance not really active surveillance?

A story that got wide coverage yesterday (in the cancer-specific media, at least) said that “research published online in the Journal of Clinical Oncology suggests that ‘active surveillance for clinical stage I (CSI) testicular cancer leads to excellent outcomes’.” … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,211 other followers